Ground-breaking oncology being developed in the Basel Area The Basel Area – covering northwestern Switzerland – has seen tremendous growth in recent years, and has become a true…martin06.09.2023
Genedata expanding its user network The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site…martin06.06.2023
Sandoz decides on Basel for headquarters Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected…martin06.01.2023
VectivBio sold for approximately 1 billion dollars The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed…martin05.23.2023
University of Basel and RocketVax present new Covid vaccine Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech…martin05.22.2023
Roche and Novartis among global leaders for research spending In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in…martin05.05.2023
Roche to found Institute for Human Biology Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will…martin05.04.2023
Provectis establishes presence in Basel Provectis Healthcare has chosen Basel as the location for its headquarters. The company is striving to become the partner of…martin04.18.2023
Alentis raises 105 million US dollars Alentis Therapeutics has received 105 million US dollars in a series C funding round. It will invest the funds in…martin04.13.2023
Spirecut establishes presence in the Basel Area Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. The company is now operating out of…martin04.04.2023